A venture capital firm with multiple offices throughout the USA currently has approximately $350 million in total assets under management. The firm is making 2-3 new investments every month from its newest fund. The firm typically makes investments ranging from $0.25 million to $6 million over the life of the company. The firm prefers to invest early at the Seed, Series A and Series B stage. The firm will consider investing in any industry segment, but there must be at least one other venture capital firm making their first investment in the company in this round. The firm only invests in US-based companies.
The firm is currently looking for new investment opportunities in the life sciences space. The firm is very opportunistic in terms of sectors, subsectors and indications. The firm is currently active in therapeutics companies that develop nucleic acid drugs and small molecules to treat oncology and infectious diseases. The firm is also active in medical devices companies that develop active diagnostic and therapeutic radiation devices, implantable devices and surgical devices.
The firm seeks to invest in private companies based in US and only acts as a co-investor in financing rounds. The firm invests in companies that already have at least one other venture capital firm making their first investment. The best time to engage with the firm is when a company has a term sheet or expression of interest from another Venture Capital Firm.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment